Recurrent B Lymphoblastic Lymphoma
5 clinical trials · Condition
◉ Watch Recurrent B Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia (NCT03991884) | University of Washington | 2019-09-24 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644) | ECOG-ACRIN Cancer Research Group | 2018-08-13 |
| Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia (NCT02981628) | Children's Oncology Group | 2017-06-19 |
Track Recurrent B Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.